Latest Regulatory News

Pancontinental Energy has identified two new prospects in its PEL 87 permit, boosting its high case prospective resources to 6.1 billion barrels of oil net to the company. While progressing farmout discussions, the company awaits a critical permit extension decision from Namibian authorities.

Jameson Resources has made significant strides in progressing its Crown Mountain coal project, securing a $3 million capital injection and navigating key board changes while advancing environmental approvals.

Medical Developments International has posted positive operating cashflow for the first half of FY26, driven by robust growth in its flagship product Penthrox across Australia and Europe, alongside progress in paediatric approvals.

ABx Group Limited has reported significant progress across its rare earths, fluorine chemical, and bauxite mining projects, underpinned by a $6 million capital raise and promising metallurgical results.

Spectur Limited reported a 4.5% increase in quarterly revenue to $2.02 million and secured $2.15 million through a share placement to fund its AI-driven Sense-Think-Act platform development.

Sarytogan Graphite Limited reports robust drilling results and key contract awards, progressing its flagship graphite project while advancing copper exploration and securing critical funding.

Catalina Resources has kicked off a substantial drilling campaign at Central Yilgarn and completed the acquisition of the Beasley Creek Gold Project, signalling a strategic expansion in Western Australia’s gold exploration landscape.

Agrimin Limited has ceased capital allocation to its Mackay Potash Project following a strategic review, while advancing exploration efforts in the promising West Arunta region.

Chalice Mining has completed a pivotal Pre-Feasibility Study for its Gonneville Palladium-Nickel-Copper Project, defining a maiden Ore Reserve and setting sights on a Final Investment Decision by mid-2028 amid robust metal prices.

Ardea Resources has made disciplined progress on its Kalgoorlie Nickel Project’s Definitive Feasibility Study, supported by renewed Major Project Status and full funding from a Japanese consortium. Completion is on track for mid-2026 amid robust resource updates and strategic partnerships.

Patrys Limited has expanded its therapeutic portfolio by acquiring Reliis Pty Ltd, adding a proprietary injectable asset targeting delirium with near-term clinical milestones. This strategic move complements its existing biologics platform and strengthens its financial position.

Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.